Bio-Path HoldingsBPTH

13F holders, Q2 2024 (June 30)
13holders +3
4new positions
1sold out
$2.00avg. 13F price*

At the end of Q2 2024, 13 institutions reported holding Bio-Path Holdings Inc. (BPTH) in their 13F filings, up 3 from Q1 2024. 4 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($194K), HRT Financial LP ($28K) and Vanguard Group Inc. ($27K).

Company
Bio-Path Holdings Inc.
CUSIP
09057N409
Latest filing quarter
Q1 2025

History

Number of 13F holders

0510152025 Q1 2024: 10Q1 2024Q2 2024: 13Q2 2024Q3 2024: 14Q3 2024Q4 2024: 22Q4 2024Q1 2025: 2Q1 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions4$244K
Exits1$20

All 13F filers, Q1 2024 → Q2 2024: 123,889 shares bought and 323 shares sold, net +123,566 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 13 holders

Armistice Capital, LLC 0.01% New 97,000 $194K
HRT Financial LP 0.00% New 14,085 $28K
Vanguard Group Inc. 0.00% No change 13,502 $27K
Geode Capital Management, LLC 0.00% New 10,866 $22K
Tower Research Capital LLC (TRC) 0.00% Add +93.0% 3,733 $7K
BlackRock Inc. 0.00% No change 2,381 $5K
UBS Group AG 0.00% Reduce -27.0% 859 $2K
Qube Research & Technologies Ltd 0.00% New 100 $200
Bank of America Corp. 0.00% Add +557.1% 46 $92
Morgan Stanley 0.00% No change 35 $70
Group One Trading LLC 0.00% No change 21 $42
Global Retirement Partners, LLC 0.00% No change 4 $8
Allworth Financial LP 0.00% No change 1 $2

"% of holder's portfolio" is BPTH's weight in each manager's 13F, not the share of Bio-Path Holdings Inc. the manager owns.